Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori Eradication and Gastric Cancer Prevention in Bhutan
NCT07211880Completed
- Start
- Dec 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rabeprazole, amoxicillin and clarithromycin in Helicobacter pylori infection. Primary endpoints: Prevalence of H. pylori at 2 months and Gastric atrophy by pepsinogen test at 2 months. Started Dec 2019; status: completed.
02
Drugs
rabeprazoleamoxicillinclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07211880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07211880.